。来到了增发价。double down 。PT 天知道,只知道extremely undervalued $Bicycle治疗(BCYC)$ $G1治疗(GTHX)$
Affimed and Roche collaborate to study AFM24 in solid tumors先上2位数, 再继续讨论......
看来看去也就BIO比较低估,当然怎么给BIO估值是个问题